• 中文核心期刊要目总览
  • 中国科技核心期刊
  • 中国科学引文数据库(CSCD)
  • 中国科技论文与引文数据库(CSTPCD)
  • 中国学术期刊文摘数据库(CSAD)
  • 中国学术期刊(网络版)(CNKI)
  • 中文科技期刊数据库
  • 万方数据知识服务平台
  • 中国超星期刊域出版平台
  • 国家科技学术期刊开放平台
  • 荷兰文摘与引文数据库(SCOPUS)
  • 日本科学技术振兴机构数据库(JST)
邹敏, 余双双, 王可, 张大永, 吴晓明, 华维一. ent-贝壳杉烯糖酯类衍生物的合成及其抗肿瘤活性的研究[J]. 中国天然药物, 2013, 11(3): 289-295.
引用本文: 邹敏, 余双双, 王可, 张大永, 吴晓明, 华维一. ent-贝壳杉烯糖酯类衍生物的合成及其抗肿瘤活性的研究[J]. 中国天然药物, 2013, 11(3): 289-295.
ZOU Min, YU Shuang-Shuang, WANG Ke, ZHANG Da-Yong, WU Xiao-Ming, HUA Wei-Yi. Glycosylation of ent-kaurene derivatives and an evaluation of their cytotoxic activities[J]. Chinese Journal of Natural Medicines, 2013, 11(3): 289-295.
Citation: ZOU Min, YU Shuang-Shuang, WANG Ke, ZHANG Da-Yong, WU Xiao-Ming, HUA Wei-Yi. Glycosylation of ent-kaurene derivatives and an evaluation of their cytotoxic activities[J]. Chinese Journal of Natural Medicines, 2013, 11(3): 289-295.

ent-贝壳杉烯糖酯类衍生物的合成及其抗肿瘤活性的研究

Glycosylation of ent-kaurene derivatives and an evaluation of their cytotoxic activities

  • 摘要: 目的:对含有exo-亚甲基环戊酮或α-亚甲基内酯药效团的ent-贝壳杉烯类化合物进行结构修饰,以改善其活性及水溶性。方法:以甜菊苷为原料,在4位羧基接入单糖而得到目标化合物,并使用MTT法对目标化合物进行抗肿瘤活性测试。结果:化合物1b对细胞株HepG2,Bel-7402,A549,MCF-7,MDA-MB-231均表现出了较好的抑制活性,IC50分别为0.12,0.91,0.35,0.08,0.07 μmol·L-1。另外,化合物3c对HepG2(IC50=0.01 μmol·L-1)具有较强的抑制作用。结论:化合物1b和3c可以作为潜在的抗肿瘤化合物进行深入研究。

     

    Abstract: AIM:To discover more active and water-soluble derivatives of tetracyclic diterpenoids containing an exo-methylene cyclopentanone or an α-methylenelactone moiety.METHODS:All of the key intermediates were synthesized from stevioside,and the target compounds were obtained through glycosylation of the 4-carboxyl group.The cytotoxicity of the target compounds against six human cancer cell lines,HepG2,Bel-7402,A549,U251,MCF-7 and MDA-MB-231,were evaluated by the MTT assay.RESULTS:Compound 1b was more effective than the positive control adriamycin against the HepG2,Bel-7402,A549,MCF-7,and MDA-MB-231 cell lines with IC50 values of 0.12,0.91,0.35,0.08,and 0.07 μmol·L-1,respectively.Moreover,compound 3c exhibited the most potent and selective cytotoxic activity against the HepG2 cell line(IC50,0.01 μmol·L-1).CONCLUSION:Compounds 1b and 3c could be considered as potential anticancer candidates for further study.

     

/

返回文章
返回